Milestone Pharmaceuticals Inc. (MIST)

NASDAQ: MIST · Real-Time Price · USD

1.185

-0.055 (-4.44%)

At close: Jul 17, 2026, 4:00 PM EDT

1.220

+0.035 (2.95%)

After-hours: Jul 17, 2026, 7:55 PM EDT

Milestone Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	1.55	1.55	-	1	5	15
Revenue Growth (YoY)	-	-	-	-80.00%	-66.67%	-
Cost of Revenue	0.01	-	-	-	-	-
Gross Profit	1.53	1.55	-	1	5	15
Selling, General & Admin	50.67	45.58	27.75	31.05	24.81	19.4
Research & Development	16.38	18.11	14.36	31.05	39.83	38.67
Total Operating Expenses	67.05	63.69	42.1	62.1	64.64	58.07
Operating Income	-65.28	-62.14	-42.1	-61.1	-59.64	-43.07
Interest Income	3.96	2.92	4.16	3.97	1.25	0.22
Interest Expense	-7.04	-3.84	-3.58	-2.55	-	-
Total Non-Operating Income (Expense)	-3.08	-0.92	0.58	1.41	1.25	0.22
Pretax Income	-68.36	-63.06	-41.52	-59.69	-58.39	-42.85
Net Income	-68.36	-63.06	-41.52	-59.69	-58.39	-42.85
Net Income to Common	-68.36	-63.06	-41.52	-59.69	-58.39	-42.85
Shares Outstanding (Basic)	100	84	62	43	42	42
Shares Outstanding (Diluted)	100	84	62	43	42	42
Shares Change (YoY)	50.69%	34.84%	44.82%	1.19%	1.47%	42.56%
EPS (Basic)	-0.67	-0.75	-0.67	-1.39	-1.38	-1.02
EPS (Diluted)	-0.67	-0.75	-0.67	-1.39	-1.38	-1.02
Free Cash Flow	-51.48	-49.34	-28.88	-46.54	-52.74	-33.22
Free Cash Flow Per Share	-0.52	-0.59	-0.46	-1.08	-1.24	-0.79
Gross Margin	99.09%	100.00%	-	100.00%	100.00%	100.00%
Operating Margin	-4222.51%	-4019.40%	-	-6109.80%	-1192.84%	-287.15%
Profit Margin	-4421.93%	-4078.78%	-	-5968.50%	-1167.76%	-285.69%
FCF Margin	-3330.08%	-3191.66%	-	-4653.60%	-1054.82%	-221.49%
EBITDA	-65.14	-62.03	-42	-61.01	-59.55	-42.98
EBITDA Margin	-4213.26%	-4012.03%	-	-6100.60%	-1191.06%	-286.53%
EBIT	-65.28	-62.14	-42.1	-61.1	-59.64	-43.07
EBIT Margin	-4222.51%	-4019.40%	-	-6109.80%	-1192.84%	-287.15%

SEC Filings: 10-K · 10-Q